[PROGRESS].
Hasegawa
Yasuhiro
Y
Department of Neurology, St. Marianna University School of Medicine.
D000203:Activities of Daily Living; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D003704:Dementia / Q000209:etiology / Q000517:prevention & control; D004311:Double-Blind Method; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D007703:Peptidyl-Dipeptidase A / Q000235:genetics; D020913:Perindopril / Q000627:therapeutic use*; D011110:Polymorphism, Genetic; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D055502:Secondary Prevention; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007703:Peptidyl-Dipeptidase A; D020913:Perindopril